Further studies by Carotti et al. and Zatloukal et al. showed that high levels of p62 in NAFLD patients lead to disease progression to fibrosis and steatohepatitis [57,58]. The gene discussed is SQSTM1; the disease is metabolic dysfunction-associated steatotic liver disease.